What is the current market valuation of the Italy ips cell-derived-organoids market?

The market valuation was $12.75 Million in 2024. Read More

What is the projected market size for the Italy ips cell-derived-organoids market by 2035?

The projected market size is $61.49 Million by 2035. Read More

What is the expected CAGR for the Italy ips cell-derived-organoids market during the forecast period 2025 - 2035?

The expected CAGR is 15.38% during the forecast period 2025 - 2035. Read More

What was the valuation of Brain Organoids in 2024?

The valuation of Brain Organoids was $2.55 Million in 2024. Read More

Which application segment holds the highest valuation in the Italy ips cell-derived-organoids market?

The Drug Discovery and Development segment holds the highest valuation at $5.1 Million in 2024. Read More

Who are the key players in the Italy ips cell-derived-organoids market?

Key players include Organovo Holdings Inc, Stemcell Technologies Inc, and Cellectis SA. Read More

What is the valuation of Liver Organoids in 2024?

The valuation of Liver Organoids was $2.5 Million in 2024. Read More

Which end user segment is projected to grow the most in the Italy ips cell-derived-organoids market?

The Pharmaceutical and Biotechnology Companies segment is projected to grow the most, with a valuation of $5.1 Million in 2024. Read More

What is the projected valuation for the Heart Organoids segment by 2035?

The projected valuation for the Heart Organoids segment is $10.0 Million by 2035. Read More

Italy iPS Cell Derived Organoids Market

Q: Which segments are included in the Italy ips cell-derived-organoids market?

The segments include Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others. Read More

ID: MRFR/LS/51884-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

Italy IPS Cell-Derived Organoids Market Research Report By Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, Others), By Application (Drug Discovery and Development, Disease Modelling, Regenerative Medicine) and By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organization) - Growth & Industry Forecast 2025 To 2035

Italy iPS Cell Derived Organoids Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)15.38%

2024 Market Size$ 12.75 Million

2025 Market Size$ 14.71 Million

2035 Market Size$ 61.49 Million

Key Players

Organovo Holdings Inc

Stemcell Technologies Inc

Cellectis SA

InSphero AG

TissUse GmbH

Hesperos GmbH

Trends

Rising Investment in Research and Development
Regulatory Advancements
Collaboration Between Academia and Industry

Opportunities

Advancements in Stem Cell Research
Growing Demand for Personalized Medicine
Collaboration Among Research Institutions

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Brain Organoids
  2. 4.1.2 Heart Organoids
  3. 4.1.3 Lung Organoids
  4. 4.1.4 Liver Organoids
  5. 4.1.5 Kidney Organoids
  6. 4.1.6 Others
2. 4.2 Medical Device, BY Application (USD Million)
  1. 4.2.1 Drug Discovery and Development
  2. 4.2.2 Disease Modelling
  3. 4.2.3 Regenerative Medicine
3. 4.3 Medical Device, BY End User (USD Million)
  1. 4.3.1 Pharmaceutical and Biotechnology Companies
  2. 4.3.2 Academic and Research Institutes
  3. 4.3.3 Contract Research Organization
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Organovo Holdings Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Stemcell Technologies Inc (CA)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Cellectis SA (FR)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 InSphero AG (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 TissUse GmbH (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hesperos GmbH (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Asterand Bioscience Inc (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Reprocell Inc (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 ITALY MARKET ANALYSIS BY TYPE
3. 6.3 ITALY MARKET ANALYSIS BY APPLICATION
4. 6.4 ITALY MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF MEDICAL DEVICE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF MEDICAL DEVICE
8. 6.8 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
11. 6.11 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
16. 6.16 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Italy Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

Brain Organoids
Heart Organoids
Lung Organoids
Liver Organoids
Kidney Organoids
Others

Medical Device By Application (USD Million, 2025-2035)

Drug Discovery and Development
Disease Modelling
Regenerative Medicine

Medical Device By End User (USD Million, 2025-2035)

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organization

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”